Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast

Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast

US Patent 10018637 · Granted Jul 10, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating systemic lupus erythematosus and the use of biomarkers as a2024
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dion2023
Treatment of immune-related and inflammatory diseases2022
Combination therapies comprising apremilast and Tyk2 inhibitors2022
(+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoind2022
Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-ac2021
Methods for determining drug efficacy for the treatment of diffuse large B-cell 2021
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dion2021
Treatment of immune-related and inflammatory diseases2021
Methods of treating psoriasis using PD-1 binding antibodies2020
Methods for treating diffuse large B-cell lymphoma and the use of biomarkers as 2020
Methods of using (+)- 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-a2020